Welcome to our dedicated page for AvePoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AvePoint, Inc. filings document the company’s financial results, governance matters, capital structure and public-company securities activity. Form 8-K reports furnish quarterly and annual operating results, including SaaS revenue, total revenue, annual recurring revenue and related financial-condition disclosures tied to the company’s cloud data protection business.
Proxy materials and annual meeting reports cover director elections, executive compensation votes, auditor ratification and board governance. Other filings address common stock offering activity under shelf registration materials, the company’s secondary listing context for common stock, and the removal of AvePoint warrants from Nasdaq listing and registration.
AvePoint director John Chi On Ho reported the sale of 650,000 shares of common stock on 09/18/2025 at $15.21 per share. The filing shows the shares were sold to provide initial liquidity for the company's secondary listing on the Singapore Exchange; no shares were sold on Nasdaq in connection with this transaction. After the sale, the reporting person is shown as beneficially owning 3,732,679 shares indirectly through Balmoral Blue Limited, subject to a disclaimer of full beneficial ownership.
The sale was executed under Rule 144 and the company's insider trading policies. The report is limited to this non-derivative equity transaction and explains the reporting person’s indirect ownership via Balmoral Blue Limited.
AvePoint Executive Chairman and Director Gong Xunkai reported a sale of 2,068,966 common shares on 09/18/2025 at $15.21 per share conducted in connection with AvePoint's secondary listing on the Singapore Exchange Securities Trading Limited (SGX-ST). The filing states the sale facilitated initial liquidity for the SGX-ST listing, was executed in accordance with Rule 144 and applicable insider trading policies, and that no shares were sold on NASDAQ. Following the transaction the reporting person beneficially owns 15,220,668 shares, comprised of shares held by affiliated LLCs and trusts for which he is trustee, with a disclaimer limiting admission of beneficial ownership.
AvePoint director and CEO Dr. Jiang Tianyi reported a sale of 2,068,966 common shares at $15.21 per share on 09/18/2025 to facilitate initial liquidity for the company's secondary listing on the Singapore Exchange (SGX-ST). The filing states the sale complied with Rule 144 and insider trading policies and that no shares were sold on NASDAQ. After the transaction Dr. Jiang is reported to beneficially own 13,841,853 shares indirectly through trusts and LLCs, with the filing listing specific affiliated entities and trusts that hold those shares.
Caci James, Chief Financial Officer and director of AvePoint, Inc. (AVPT), reported a sale of 216,000 shares of the issuer's common stock on 09/18/2025 at a price of $15.21 per share executed on the Singapore Exchange Securities Trading Limited (SGX-ST) to facilitate initial liquidity related to the company's SGX-ST secondary listing. The filing states the transaction complied with Rule 144 and the company's insider trading policies. Following the reported sale, the reporting person beneficially owns 213,030 shares, which include non-RSU common stock and both vested and unvested restricted stock units (RSUs) granted under the 2021 Equity Incentive Plan as previously disclosed.
AvePoint insider sale of 500,000 shares to support SGX secondary listing. Brian Michael Brown, who serves as Chief Legal Officer and a Director, sold 500,000 shares of AvePoint common stock on 09/18/2025 at $15.21 per share as part of the company’s secondary listing on the Singapore Exchange to facilitate initial liquidity. The filing states no shares were sold on NASDAQ and the transaction was executed in accordance with Rule 144 and company insider trading policies. After the sale the report shows 640,288 shares beneficially owned indirectly, held by the Brian M. Brown Revocable Trust.
AvePoint, Inc. (AVPT) Executive Chairman and Director Gong Xunkai reported a Form 4 disclosing a routine tax-withholding share disposition related to equity vesting. On 09/12/2025 the filing shows 4,025 shares of common stock were disposed of at a price of $15.61 per share to satisfy tax withholding obligations arising from the net settlement of vested restricted stock units (RSUs). After the transaction, the reporting person beneficially owned 770,202 shares, a total that includes both non-RSU common stock and vested and unvested RSUs previously reported. The Form 4 identifies Gong Xunkai as a Director, 10% owner and Executive Chairman. The filing states the withholding was an exempt transaction under Rule 16b-3 and not a discretionary sale by the reporting person.
Jiang Tianyi, who serves as AvePoint, Inc.'s Chief Executive Officer, Director and a reported 10% owner, reported a transaction on 09/12/2025 involving the company's common stock. The filing shows 2,914 shares were disposed of at a price of $15.61 per share. The Form 4 explains this disposition was an exempt net settlement where the issuer withheld shares to satisfy income tax withholding obligations related to vested restricted stock units (RSUs).
After the transaction, the reporting person is shown as beneficially owning 556,340 shares, which combines non-RSU common stock and aggregate vested and unvested RSUs previously disclosed. The form was signed by an attorney-in-fact on 09/16/2025.
Brian Michael Brown, Chief Legal Officer and director of AvePoint, Inc. (AVPT), reported a transaction on Form 4 showing a disposition of 5,010 shares on 09/12/2025. The filing states the transaction was an exempt withholding to satisfy tax obligations in connection with the net settlement of restricted stock units (RSUs) granted under the company’s 2021 Equity Incentive Plan, at an effective price of $15.61 per share.
After the withholding, the reporting person beneficially owned 1,140,288 shares, which includes both non‑RSU common stock and aggregate vested and unvested RSUs previously reported. The filing is signed and dated 09/16/2025.
AvePoint, Inc. (AVPT) Chief Financial Officer Caci James reported a tax-withholding disposition of company shares tied to RSU vesting. The Form 4 shows a disposition of 6,120 common shares on 09/12/2025 at a price of $15.61 per share, described as withholding to satisfy income tax obligations related to net settlement of restricted stock units. After the transaction the reporting person beneficially owns 668,493 shares, which includes both non-RSU common stock and aggregate vested and unvested RSUs held under previously disclosed vesting schedules. The filing is signed by an attorney-in-fact on behalf of the reporting person.
AvePoint, Inc. entered into an underwriting agreement on September 16, 2025 to facilitate an underwritten public offering of 13,290,360 shares of its common stock, to be sold by certain selling securityholders at S$19.50 (approximately US$15.21) per share. The underwriters have a 30-day option to purchase up to an additional 1,993,550 shares. The Company applied for a secondary listing by introduction on the SGX Main Board and received a letter of eligibility; trading on SGX-ST under the symbol AVP is expected to begin September 19, 2025 following settlement of the Offering.
The Offering is a sale by selling securityholders, so AvePoint will not receive proceeds (approximately US$202 million expected to the sellers before expenses). The Company agreed to pay certain selling expenses but will not pay underwriting discounts or commissions. The filing references customary representations, indemnities, exhibits including the underwriting agreement, legal opinion, and media release.